Skip to main content
. 2020 Jul 13;43(9):2025–2033. doi: 10.2337/dc20-0408

Table 1.

Baseline characteristics

Participants, n 19
Female sex, n (%) 11 (58)
Age (years) 43 (14)
Caucasian, n (%) 19 (100)
Diabetes duration (years) 20 (8–34)
BMI (kg/m2) 24.8 (22.0–25.7)
Fasting plasma glucose (mmol/L) 8.9 (2.3)
HbA1c (%) 7.4 (0.7)
HbA1c (mmol/mol) 57.1 (7.3)
HOMA-IR 0.9 (0.7–1.3)
Complications, n
 Retinopathy 5
 Microalbuminuria 1
 Transient ischemic attack 1
Comorbidities, n
 Hypertension 3
 Hypercholesterolemia 9
 Multiple sclerosis 1
Treatment, n
 Glimepiride 18
 Diet 1

Data are mean (SD) or median (interquartile range) unless otherwise indicated. Diabetes duration is from manifest diabetes (first measurement of HbA1c ≥6.5% [≥48 mmol/mol]). HOMA-IR, HOMA of insulin resistance.